Cite

HARVARD Citation

    Jacquin, J. et al. (n.d.). 220PSefety profile of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: The French HERMIONE non-interventional prospective study. Annals of oncology. p. . [Online]. 
  
Back to record